Changes

A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to Chronic myeloid leukemia (CML) and other hematological neoplasms, but this fusion gene appears to be rare (12, 13, 14, also see '''[http://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html] Atlas of Genetics and Cytogenetics in Oncology and Haematology]''').

A small number of individual patients have been described with a BCR-JAK2 (Janus Kinase 2) fusion gene leading to Chronic myeloid leukemia (CML) and other hematological neoplasms, but this fusion gene appears to be rare (12, 13, 14, also see '''[http://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html] Atlas of Genetics and Cytogenetics in Oncology and Haematology]''').

BCR-FGFR1

A small number of chronic myeloproliferative disorders patients have been described with BCR-FGFR1 and BCR-PDCFRA fusion genes (14).

 

BCR-PDCFRA